Prosecution Insights
Last updated: April 19, 2026

Examiner: ZEMAN, ROBERT A

Tech Center 1600 • Art Units: 1645

This examiner grants 54% of resolved cases

Performance Statistics

53.9%
Allow Rate
-6.1% vs TC avg
817
Total Applications
+27.9%
Interview Lift
1388
Avg Prosecution Days
Based on 766 resolved cases, 2023–2026

Rejection Statute Breakdown

4.4%
§101 Eligibility
16.6%
§102 Novelty
21.5%
§103 Obviousness
40.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17914274 ANTI-ACINETOBACTER BAUMANNII POLYCLONAL ANTIBODY (AB-pAb), AND USES THEREOF Final Rejection The Regents of the University of California
17299871 POLYMER COMPOSITIONS WITH IMPROVED STABILITY FOR NITROGEN FIXING MICROBIAL PRODUCTS Final Rejection Pivot Bio, Inc.
18531938 METHOD TO PROVIDE LONG-LASTING CLEANING Non-Final OA The Procter & Gamble Company
18322442 METHODS FOR DIAGNOSING GASTRIC INTESTINAL METAPLASIA Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18153727 STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF Non-Final OA NEW YORK UNIVERSITY
18270611 METHODS AND COMPOSITION FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER Non-Final OA The General Hospital Corporation
18995578 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS FOR ALLEVIATING PARKINSON'S DISEASE AND USE THEREOF Non-Final OA WECARE PROBIOTICS CO., LTD.
16331863 THERMOSTABLE VARIANTS OF P. FALCIPARUM PFRH5 WHICH CAN BE PRODUCED IN BACTERIAL CELLS Non-Final OA YEDA RESEARCH AND DEVELOPMENT CO. LTD.
18696298 EFFECT OF A PROBIOTIC COMPOSITION ON VAGINAL LACTOBACILLUS SPECIES Non-Final OA INTERNATIONAL N&H DENMARK APS
18566194 BACTERIAL STRAINS FOR USE IN PREVENTING, TREATING AND/OR REDUCING SYMPTOMS ASSOCIATED WITH A RHINOVIRUS-INDUCED COLD INFECTION Non-Final OA International N&H Denmark APS
17613911 LEADER SEQUENCE Final Rejection THE UNIVERSITY OF WARWICK
18191919 Bifidobacterium longum for Preventing and/or Treating Essential Hypertension Non-Final OA Jiangnan University
16347861 DNA ANTIBODY CONSTRUCTS FOR USE AGAINST LYME DISEASE Final Rejection THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
17641031 COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION Non-Final OA INTERVET INC.
18571132 BROAD SPECTRUM PATHOGEN CONTROL IN PLANTS Non-Final OA FUNDACIÓN CENTRO DE EXCELENCIA EN INVESTIGACIÓN DE MEDICAMENTOS INNOVADORES EN ANDALUCÍA, MEDINA
18036743 PLANT DISEASE CONTROL COMPOSITION COMPRISING CULTURE BROTH OF Streptomyces sp. JCK-6141 STRAIN OR EXTRACT OF CULTURE BROTH OF STRAIN, PREPARATION METHOD THEREFOR AND PLANT DISEASE CONTROL METHOD Non-Final OA INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
16962274 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER Final Rejection Vedanta Biosciences, Inc.
18479501 PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS Non-Final OA Evaxion Biotech A/S
18038901 BIOMARKERS FOR MYCOBACTERIUM AVIUM PARATUBERCULOSIS Non-Final OA ABERYSTWYTH UNIVERSITY
18256547 AGRICULTURAL FORMULATION COMPRISING AT LEAST ONE BACTERIAL STRAIN B. SAFENSIS RGM 2450, AND/OR A BACTERIAL STRAIN B. SIAMENSIS RGM 2529 AND AGRICULTURAL EXCIPIENTS; USE OF THE FORMULATION AND METHOD FOR STIMULATING GROWTH AND/OR INCREASING CROP YIELDS AND/OR PROTECTING CROPS AGAINST DISEASES AND PESTS Non-Final OA BLANES SPA
17758139 IMMUNOTHERAPEUTIC TREATMENT OF CANCER Final Rejection IMMODULON THERAPEUTICS LIMITED
18033232 LACTIC ACID BACTERIUM FOR TREATMENT OF AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY Final Rejection Su Ching HU
18027614 NOVEL LACTIC ACID BACTERIA ISOLATED FROM AGED MEAT, AND USE THEREOF Final Rejection KOOKMINBIO, CORP.
18024917 COMPOSITION FOR USE IN FOOD SUPPLEMENTS AND/OR COSMETIC PRODUCTS, COMPRISING BACILLUS SUBTILIS Non-Final OA INSTITUT DR. RILLING HEALTHCARE GMBH
17488545 VACCINE AGAINST ACINETOBACTER BAUMANNII BASED ON CELLULAR COMPONENTS DEFICIENT IN LIPOPOLYSACCHARIDE Non-Final OA SERVICIO ANDALUZ DE SALUD
17896847 COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OR PREVENTION OF CONDITIONS ASSOCIATED WITH HYPERPROLIFERATIVE CELLULAR DIVISION, DIABETES, IMMUNODEFICIENCY DISEASES, ALZHEIMER'S DISEASE OR AUTOIMMUNE DISEASES, AND TESTING SYSTEM AND METHOD Final Rejection Chai Foundation for Medical Research & Life Extension, Inc.
17779676 COMPOSITIONS FOR IMPROVING ATHLETIC PERFORMANCE AND METHODS OF USE THEREOF Non-Final OA FITBIOMICS INC.
17627796 Novel Xanthomonas Strains and Related Methods Non-Final OA Geoffrey Gardiner Dairy Foundation Limited
16475541 USE OF THE CPCR REGULATOR GENE FOR OBTAINING NEW RECOMBINANT STRAINS OF BACILLUS THURINGIENSIS WITH REDUCED SPORULATION CAPACITY Final Rejection Institute of Plant Protection, Chinese Academy of Agricultural Sciences

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month